Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP joins Antares

Bruce Freundlich appointed senior VP, medical

Antares Pharma has appointed Dr Bruce Freundlich as senior VP, medical.

Dr Freundlich has extensive experience in both academia and industry, including spells at Merck & Co, Wyeth and Pfizer.

During his time at Pfizer from 2009 to 2010 he served as VP, inflammation. He assumed the role after his previous company Wyeth - where he served as VP - global medical affairs, was taken over by Pfizer.

Most recently, he served as president of New Light Medical Consultants.

Antares Pharma has made several senior appointments in the past year, including a new VP, clinical development, and senior VP, pharma sales and marketing, as the company looks to commercialise Otrexup (methotrexate) for arthritis and advance the development of testosterone replacement therapy Vibex QS T.

“Everyone associated with Antares is excited about his joining the organisation at a time when we are establishing our own commercial presence in the rheumatology field,” said Dr Paul Wotton, CEO of Antares.

Dr Freundlich's experience in rheumatology includes his position as chief of clinical rheumatology at the University of Pennsylvania in the US.

6th November 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....